These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9157075)

  • 21. Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951).
    Aass N; De Mulder PH; Mickisch GH; Mulders P; van Oosterom AT; van Poppel H; Fossa SD; de Prijck L; Sylvester RJ
    J Clin Oncol; 2005 Jun; 23(18):4172-8. PubMed ID: 15961764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II trial of 13-cis-retinoic acid plus interferon-alpha in recurrent head and neck cancer.
    Voravud N; Lippman SM; Weber RS; Rodriquez GI; Yee D; Dimery IW; Earley CL; Von Hoff DD; Hong WK
    Invest New Drugs; 1993 Feb; 11(1):57-60. PubMed ID: 8349437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low activity of 13-cis-retinoic acid plus interferon alpha 2a in advanced renal cell carcinoma.
    Jaremtchuk AV; Aman EF; Ponce W; Zarbá JJ; Ferro AM; Alvarez R; Vigo SA
    Am J Clin Oncol; 2002 Apr; 25(2):123-5. PubMed ID: 11943887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinoids, cisplatin and interferon-alpha in recurrent or metastatic cervical squamous cell carcinoma: clinical results of 2 phase II trials.
    Braud AC; Gonzague L; Bertucci F; Genre D; Camerlo J; Gravis G; Goncalves A; Moutardier V; Viret F; Maraninchi D; Viens P
    Eur Cytokine Netw; 2002; 13(1):115-20. PubMed ID: 11956030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergism.
    Weisman RA; Christen R; Los G; Jones V; Kerber C; Seagren S; Glassmeyer S; Orloff LA; Wong W; Kirmani S; Howell S
    Otolaryngol Head Neck Surg; 1998 May; 118(5):597-602. PubMed ID: 9591856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of interferon-alpha and isotretinoin in patients with advanced, refractory lymphoid malignancies.
    Tsimberidou AM; Giles F; Romaguera J; Duvic M; Kurzrock R
    Cancer; 2004 Feb; 100(3):574-80. PubMed ID: 14745875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II trial of subcutaneous interleukin-2, subcutaneous interferon-alpha, 5-fluorouracil and cis-retinoic acid in the treatment of renal cell carcinoma: final results of cancer biotherapy research group 94-10.
    Soori G; Dillman RO; Wiemann MC; Stark JJ; Tai F; DePriest CB; Church CK; Schulof R
    Cancer Biother Radiopharm; 2002 Apr; 17(2):165-73. PubMed ID: 12030110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial.
    Shin DM; Khuri FR; Murphy B; Garden AS; Clayman G; Francisco M; Liu D; Glisson BS; Ginsberg L; Papadimitrakopoulou V; Myers J; Morrison W; Gillenwater A; Ang KK; Lippman SM; Goepfert H; Hong WK
    J Clin Oncol; 2001 Jun; 19(12):3010-7. PubMed ID: 11408495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of alpha-interferon 2a (alpha-IFN 2a) and 13-cis-retinoic acid (13cRA) in recurrent, pre-treated squamous-cell carcinoma of head and neck (SCCHN).
    Toma S; Airoldi M; Palumbo R; Raffo P; Bumma C
    Int J Cancer; 1997 Feb; 70(4):491-3. PubMed ID: 9033664
    [No Abstract]   [Full Text] [Related]  

  • 30. Interferon-alpha 2a, 13-cis-retinoic acid and radiotherapy for locally advanced carcinoma of the cervix: a pilot study.
    Park TK; Lee JP; Kim SN; Choi SM; Kudelka AP; Kavanagh JJ
    Eur J Gynaecol Oncol; 1998; 19(1):35-8. PubMed ID: 9476056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon alpha-2a as first-line endocrine treatments in advanced breast cancer: updated results of a phase II, prospective, randomised multicentre trial.
    Chiesa MD; Passalacqua R; Michiara M; Franciosi V; Di Costanzo F; Bisagni G; Camisa R; Buti S; Tomasello G; Cocconi G;
    Acta Biomed; 2007 Dec; 78(3):204-9. PubMed ID: 18330080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon alpha-2a and 13-cis-retinoic acid in patients with metastatic renal cell cancer.
    Jacobs A; Gold P; Weiden P; Aboulafia D; Rudolph R; Picozzi V; Thompson J
    Cancer Invest; 2000; 18(5):417-21. PubMed ID: 10834025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I-II study of 5-fluorouracil, recombinant interferon alpha2a, and cisplatin in combination with external beam radiation therapy followed by surgery in patients with locally advanced carcinoma of the esophagus.
    Damle S; Beitler JJ; Haynes H; Camacho M; Wolf E; Wadler S
    Am J Clin Oncol; 1999 Aug; 22(4):391-5. PubMed ID: 10440197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon.
    Dunst J; Hänsgen G; Lautenschläger C; Füchsel G; Becker A
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):367-73. PubMed ID: 10030263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer.
    Shin DM; Glisson BS; Khuri FR; Clifford JL; Clayman G; Benner SE; Forastiere AA; Ginsberg L; Liu D; Lee JJ; Myers J; Goepfert H; Lotan R; Hong WK; Lippman SM
    J Clin Oncol; 2002 Jan; 20(2):364-70. PubMed ID: 11786562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Granulocyte-macrophage-colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma: results of two phase II clinical trials.
    Ryan CW; Vogelzang NJ; Dumas MC; Kuzel T; Stadler WM
    Cancer; 2000 Mar; 88(6):1317-24. PubMed ID: 10717612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. All-trans retinoic acid and interferon-alpha-2a in patients with metastatic or recurrent carcinoma of the uterine cervix: clinical and pharmacokinetic studies. New York Gynecologic Oncology Group.
    Wadler S; Schwartz EL; Haynes H; Rameau R; Quish A; Mandeli J; Gallagher R; Hallam S; Fields A; Goldberg G; McGill F; Jennings S; Wallach RC; Runowicz CD
    Cancer; 1997 Apr; 79(8):1574-80. PubMed ID: 9118041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II study of 13-cis-retinoic acid plus interferon-alpha 2a in heavily pretreated squamous carcinoma of the cervix.
    Hallum AV; Alberts DS; Lippman SM; Inclan L; Shamdas GJ; Childers JM; Surwit EA; Modiano M; Hatch KD
    Gynecol Oncol; 1995 Mar; 56(3):382-6. PubMed ID: 7705672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of 32 cervico-uterine cancer patients with 13-cis-retinoic acid and interferon alpha].
    Paredes Espinoza M; Lippman SM; Kavanagh JJ; Delgadillo Madrueño F; Paredes Casillas P; Bañuelos Acosta O; Alvarez Márquez V; Buenrostro Ahued MA; de Alba Ayala I; Arias Castro G
    Rev Invest Clin; 1994; 46(2):105-11. PubMed ID: 8052740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial.
    Weiss GR; Liu PY; Alberts DS; Peng YM; Fisher E; Xu MJ; Scudder SA; Baker LH; Moore DF; Lippman SM
    Gynecol Oncol; 1998 Dec; 71(3):386-90. PubMed ID: 9887236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.